nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—Doxorubicin—kidney cancer	0.236	1	CrCtD
Daunorubicin—Anthracyclines—Doxorubicin—kidney cancer	0.192	0.657	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Doxorubicin—kidney cancer	0.1	0.343	CiPCiCtD
Daunorubicin—Epirubicin—Doxorubicin—kidney cancer	0.0498	0.333	CrCrCtD
Daunorubicin—Idarubicin—Doxorubicin—kidney cancer	0.0498	0.333	CrCrCtD
Daunorubicin—Valrubicin—Doxorubicin—kidney cancer	0.0498	0.333	CrCrCtD
Daunorubicin—CYP1A1—kidney cancer	0.0428	0.653	CbGaD
Daunorubicin—ABCB1—kidney cancer	0.0228	0.347	CbGaD
Daunorubicin—NR5A1—Vinblastine—kidney cancer	0.0209	0.115	CbGbCtD
Daunorubicin—YWHAG—Doxorubicin—kidney cancer	0.0128	0.0706	CbGbCtD
Daunorubicin—ABCC6—Dactinomycin—kidney cancer	0.0127	0.0701	CbGbCtD
Daunorubicin—ABCC6—Vinblastine—kidney cancer	0.00796	0.0439	CbGbCtD
Daunorubicin—ABCC10—Gemcitabine—kidney cancer	0.00768	0.0423	CbGbCtD
Daunorubicin—ABCC10—Paclitaxel—kidney cancer	0.00694	0.0382	CbGbCtD
Daunorubicin—ABCC10—Vincristine—kidney cancer	0.00598	0.033	CbGbCtD
Daunorubicin—POR—Doxorubicin—kidney cancer	0.00532	0.0293	CbGbCtD
Daunorubicin—ABCC6—Doxorubicin—kidney cancer	0.00489	0.027	CbGbCtD
Daunorubicin—CYP1B1—Erlotinib—kidney cancer	0.00412	0.0227	CbGbCtD
Daunorubicin—ABCB11—Paclitaxel—kidney cancer	0.00377	0.0208	CbGbCtD
Daunorubicin—CYP1B1—Paclitaxel—kidney cancer	0.00377	0.0208	CbGbCtD
Daunorubicin—ABCC1—Dactinomycin—kidney cancer	0.00375	0.0207	CbGbCtD
Daunorubicin—ABCC10—Doxorubicin—kidney cancer	0.00374	0.0206	CbGbCtD
Daunorubicin—ABCB11—Vinblastine—kidney cancer	0.00331	0.0182	CbGbCtD
Daunorubicin—ABCB11—Vincristine—kidney cancer	0.00325	0.0179	CbGbCtD
Daunorubicin—XDH—Doxorubicin—kidney cancer	0.00306	0.0168	CbGbCtD
Daunorubicin—CYP3A5—Temsirolimus—kidney cancer	0.00289	0.0159	CbGbCtD
Daunorubicin—ABCG2—Pazopanib—kidney cancer	0.00274	0.0151	CbGbCtD
Daunorubicin—ABCC1—Paclitaxel—kidney cancer	0.00268	0.0148	CbGbCtD
Daunorubicin—TOP2A—Doxorubicin—kidney cancer	0.0026	0.0143	CbGbCtD
Daunorubicin—ABCG2—Dactinomycin—kidney cancer	0.00251	0.0138	CbGbCtD
Daunorubicin—ABCC1—Vinblastine—kidney cancer	0.00235	0.0129	CbGbCtD
Daunorubicin—ABCC1—Vincristine—kidney cancer	0.00231	0.0127	CbGbCtD
Daunorubicin—SLC22A2—Vinblastine—kidney cancer	0.00213	0.0117	CbGbCtD
Daunorubicin—CYP1B1—Doxorubicin—kidney cancer	0.00203	0.0112	CbGbCtD
Daunorubicin—ABCB11—Doxorubicin—kidney cancer	0.00203	0.0112	CbGbCtD
Daunorubicin—ABCC2—Paclitaxel—kidney cancer	0.00198	0.0109	CbGbCtD
Daunorubicin—ABCG2—Erlotinib—kidney cancer	0.00196	0.0108	CbGbCtD
Daunorubicin—ABCB1—Temsirolimus—kidney cancer	0.00188	0.0104	CbGbCtD
Daunorubicin—CYP1A1—Erlotinib—kidney cancer	0.00181	0.00996	CbGbCtD
Daunorubicin—ABCG2—Paclitaxel—kidney cancer	0.00179	0.00988	CbGbCtD
Daunorubicin—ABCC2—Sorafenib—kidney cancer	0.00176	0.0097	CbGbCtD
Daunorubicin—ABCC2—Vinblastine—kidney cancer	0.00174	0.00958	CbGbCtD
Daunorubicin—ABCC2—Vincristine—kidney cancer	0.00171	0.00942	CbGbCtD
Daunorubicin—CYP3A4—Everolimus—kidney cancer	0.00167	0.00921	CbGbCtD
Daunorubicin—ABCG2—Sorafenib—kidney cancer	0.00159	0.00877	CbGbCtD
Daunorubicin—ABCG2—Vincristine—kidney cancer	0.00155	0.00852	CbGbCtD
Daunorubicin—ABCC1—Doxorubicin—kidney cancer	0.00144	0.00795	CbGbCtD
Daunorubicin—ABCC2—Sunitinib—kidney cancer	0.00143	0.00786	CbGbCtD
Daunorubicin—ABCG2—Sunitinib—kidney cancer	0.00129	0.00711	CbGbCtD
Daunorubicin—SLC22A2—nephron—kidney cancer	0.00117	0.0987	CbGeAlD
Daunorubicin—CYP1A2—Pazopanib—kidney cancer	0.00113	0.00623	CbGbCtD
Daunorubicin—CYP3A4—Temsirolimus—kidney cancer	0.00113	0.00622	CbGbCtD
Daunorubicin—CYP3A5—Erlotinib—kidney cancer	0.00108	0.00598	CbGbCtD
Daunorubicin—ABCC2—Doxorubicin—kidney cancer	0.00107	0.00589	CbGbCtD
Daunorubicin—CYP3A5—Paclitaxel—kidney cancer	0.000993	0.00547	CbGbCtD
Daunorubicin—ABCB1—Pazopanib—kidney cancer	0.000989	0.00545	CbGbCtD
Daunorubicin—ABCG2—Doxorubicin—kidney cancer	0.000966	0.00532	CbGbCtD
Daunorubicin—ABCB1—Dactinomycin—kidney cancer	0.000905	0.00499	CbGbCtD
Daunorubicin—CYP3A5—Sorafenib—kidney cancer	0.000882	0.00486	CbGbCtD
Daunorubicin—CYP3A5—Vincristine—kidney cancer	0.000856	0.00472	CbGbCtD
Daunorubicin—CYP1A2—Erlotinib—kidney cancer	0.000807	0.00445	CbGbCtD
Daunorubicin—ABCB1—Gemcitabine—kidney cancer	0.000715	0.00394	CbGbCtD
Daunorubicin—CYP3A5—Sunitinib—kidney cancer	0.000715	0.00394	CbGbCtD
Daunorubicin—ABCB1—Erlotinib—kidney cancer	0.000706	0.00389	CbGbCtD
Daunorubicin—CYP1A2—Sorafenib—kidney cancer	0.000656	0.00362	CbGbCtD
Daunorubicin—ABCB1—Paclitaxel—kidney cancer	0.000646	0.00356	CbGbCtD
Daunorubicin—CYP3A4—Pazopanib—kidney cancer	0.000593	0.00327	CbGbCtD
Daunorubicin—ABCB1—Sorafenib—kidney cancer	0.000574	0.00316	CbGbCtD
Daunorubicin—Epirubicin—AURKA—kidney cancer	0.000568	0.61	CrCbGaD
Daunorubicin—ABCB1—Vinblastine—kidney cancer	0.000567	0.00312	CbGbCtD
Daunorubicin—ABCB1—Vincristine—kidney cancer	0.000557	0.00307	CbGbCtD
Daunorubicin—ABCB1—Sunitinib—kidney cancer	0.000465	0.00256	CbGbCtD
Daunorubicin—CYP3A4—Erlotinib—kidney cancer	0.000423	0.00233	CbGbCtD
Daunorubicin—CYP1A2—urine—kidney cancer	0.000417	0.0352	CbGeAlD
Daunorubicin—NR5A1—gonad—kidney cancer	0.000407	0.0344	CbGeAlD
Daunorubicin—CYP3A4—Paclitaxel—kidney cancer	0.000387	0.00213	CbGbCtD
Daunorubicin—ABCB1—Doxorubicin—kidney cancer	0.000348	0.00192	CbGbCtD
Daunorubicin—CYP3A4—Sorafenib—kidney cancer	0.000344	0.0019	CbGbCtD
Daunorubicin—CYP3A4—Vinblastine—kidney cancer	0.00034	0.00187	CbGbCtD
Daunorubicin—CYP3A4—Vincristine—kidney cancer	0.000334	0.00184	CbGbCtD
Daunorubicin—Doxorubicin—AURKA—kidney cancer	0.000326	0.35	CrCbGaD
Daunorubicin—ABCC6—renal system—kidney cancer	0.000319	0.0269	CbGeAlD
Daunorubicin—TOP2B—nephron tubule—kidney cancer	0.000318	0.0269	CbGeAlD
Daunorubicin—ABCC6—kidney—kidney cancer	0.000308	0.026	CbGeAlD
Daunorubicin—CYP3A4—urine—kidney cancer	0.000302	0.0255	CbGeAlD
Daunorubicin—YWHAG—renal system—kidney cancer	0.0003	0.0253	CbGeAlD
Daunorubicin—XDH—renal system—kidney cancer	0.000293	0.0247	CbGeAlD
Daunorubicin—YWHAG—kidney—kidney cancer	0.00029	0.0245	CbGeAlD
Daunorubicin—TOP2B—renal system—kidney cancer	0.000289	0.0244	CbGeAlD
Daunorubicin—XDH—kidney—kidney cancer	0.000283	0.0239	CbGeAlD
Daunorubicin—YWHAG—cortex of kidney—kidney cancer	0.000282	0.0239	CbGeAlD
Daunorubicin—TOP2B—kidney—kidney cancer	0.000279	0.0236	CbGeAlD
Daunorubicin—CYP3A4—Sunitinib—kidney cancer	0.000279	0.00154	CbGbCtD
Daunorubicin—TOP2B—cortex of kidney—kidney cancer	0.000272	0.023	CbGeAlD
Daunorubicin—YWHAG—gonad—kidney cancer	0.000269	0.0227	CbGeAlD
Daunorubicin—YWHAG—cardiac atrium—kidney cancer	0.000269	0.0227	CbGeAlD
Daunorubicin—TOP2B—gonad—kidney cancer	0.000259	0.0219	CbGeAlD
Daunorubicin—TOP2B—cardiac atrium—kidney cancer	0.000259	0.0219	CbGeAlD
Daunorubicin—SLC22A2—nephron tubule—kidney cancer	0.000252	0.0213	CbGeAlD
Daunorubicin—POR—nephron tubule—kidney cancer	0.000251	0.0212	CbGeAlD
Daunorubicin—SLC22A2—renal system—kidney cancer	0.000229	0.0194	CbGeAlD
Daunorubicin—SLC22A2—kidney—kidney cancer	0.000222	0.0187	CbGeAlD
Daunorubicin—SLC22A2—cortex of kidney—kidney cancer	0.000216	0.0182	CbGeAlD
Daunorubicin—POR—cortex of kidney—kidney cancer	0.000215	0.0181	CbGeAlD
Daunorubicin—CYP3A4—Doxorubicin—kidney cancer	0.000209	0.00115	CbGbCtD
Daunorubicin—POR—cardiac atrium—kidney cancer	0.000204	0.0173	CbGeAlD
Daunorubicin—ABCC10—renal system—kidney cancer	0.000181	0.0153	CbGeAlD
Daunorubicin—ABCC10—kidney—kidney cancer	0.000175	0.0148	CbGeAlD
Daunorubicin—ABCC10—cortex of kidney—kidney cancer	0.00017	0.0144	CbGeAlD
Daunorubicin—ABCC10—gonad—kidney cancer	0.000162	0.0137	CbGeAlD
Daunorubicin—ABCC10—cardiac atrium—kidney cancer	0.000162	0.0137	CbGeAlD
Daunorubicin—TOP2A—Docetaxel—Paclitaxel—kidney cancer	0.00016	0.235	CbGdCrCtD
Daunorubicin—ABCC2—nephron tubule—kidney cancer	0.00016	0.0135	CbGeAlD
Daunorubicin—CYP1B1—nephron tubule—kidney cancer	0.000157	0.0132	CbGeAlD
Daunorubicin—ABCC2—renal system—kidney cancer	0.000145	0.0123	CbGeAlD
Daunorubicin—CYP1B1—renal system—kidney cancer	0.000142	0.012	CbGeAlD
Daunorubicin—ABCC2—kidney—kidney cancer	0.00014	0.0119	CbGeAlD
Daunorubicin—CYP1B1—kidney—kidney cancer	0.000138	0.0116	CbGeAlD
Daunorubicin—ABCC2—cortex of kidney—kidney cancer	0.000137	0.0116	CbGeAlD
Daunorubicin—CYP1B1—cortex of kidney—kidney cancer	0.000134	0.0113	CbGeAlD
Daunorubicin—CYP1B1—gonad—kidney cancer	0.000128	0.0108	CbGeAlD
Daunorubicin—ABCC1—cortex of kidney—kidney cancer	0.00012	0.0102	CbGeAlD
Daunorubicin—ABCG2—nephron tubule—kidney cancer	0.000117	0.00985	CbGeAlD
Daunorubicin—ABCC1—cardiac atrium—kidney cancer	0.000115	0.00968	CbGeAlD
Daunorubicin—CYP3A5—nephron tubule—kidney cancer	0.000108	0.00914	CbGeAlD
Daunorubicin—CYP1A2—renal system—kidney cancer	0.000102	0.00861	CbGeAlD
Daunorubicin—CYP1A1—renal system—kidney cancer	0.000101	0.0085	CbGeAlD
Daunorubicin—CYP3A5—renal system—kidney cancer	9.83e-05	0.00831	CbGeAlD
Daunorubicin—CYP1A1—kidney—kidney cancer	9.72e-05	0.00821	CbGeAlD
Daunorubicin—CYP3A5—kidney—kidney cancer	9.51e-05	0.00803	CbGeAlD
Daunorubicin—CYP3A5—cortex of kidney—kidney cancer	9.26e-05	0.00782	CbGeAlD
Daunorubicin—CYP1A1—cardiac atrium—kidney cancer	9.01e-05	0.00761	CbGeAlD
Daunorubicin—TOP2A—Vindesine—Vinblastine—kidney cancer	8.13e-05	0.12	CbGdCrCtD
Daunorubicin—TOP2A—Vindesine—Vincristine—kidney cancer	8.13e-05	0.12	CbGdCrCtD
Daunorubicin—TOP2A—Gefitinib—Erlotinib—kidney cancer	7.66e-05	0.113	CbGdCrCtD
Daunorubicin—CYP3A4—renal system—kidney cancer	7.38e-05	0.00623	CbGeAlD
Daunorubicin—CYP3A4—kidney—kidney cancer	7.14e-05	0.00603	CbGeAlD
Daunorubicin—ABCB1—nephron tubule—kidney cancer	5.75e-05	0.00485	CbGeAlD
Daunorubicin—ABCB1—renal system—kidney cancer	5.22e-05	0.00441	CbGeAlD
Daunorubicin—TOP2A—Vinorelbine—Vincristine—kidney cancer	5.13e-05	0.0755	CbGdCrCtD
Daunorubicin—TOP2A—Vinorelbine—Vinblastine—kidney cancer	5.13e-05	0.0755	CbGdCrCtD
Daunorubicin—ABCB1—kidney—kidney cancer	5.05e-05	0.00427	CbGeAlD
Daunorubicin—ABCB1—cortex of kidney—kidney cancer	4.92e-05	0.00416	CbGeAlD
Daunorubicin—ABCB1—gonad—kidney cancer	4.69e-05	0.00396	CbGeAlD
Daunorubicin—TOP2A—Vincristine—Vinblastine—kidney cancer	4.39e-05	0.0645	CbGdCrCtD
Daunorubicin—Doxorubicin—ABCB1—kidney cancer	3.73e-05	0.04	CrCbGaD
Daunorubicin—TOP2A—Vinblastine—Vincristine—kidney cancer	3.53e-05	0.0519	CbGdCrCtD
Daunorubicin—TOP2A—Cytarabine—Gemcitabine—kidney cancer	2.88e-05	0.0424	CbGdCrCtD
Daunorubicin—TOP2A—Idarubicin—Doxorubicin—kidney cancer	2.47e-05	0.0364	CbGdCrCtD
Daunorubicin—TOP2A—Epirubicin—Doxorubicin—kidney cancer	2.47e-05	0.0364	CbGdCrCtD
Daunorubicin—TOP2A—Azacitidine—Gemcitabine—kidney cancer	2.07e-05	0.0304	CbGdCrCtD
Daunorubicin—Body temperature increased—Dactinomycin—kidney cancer	1.78e-05	0.000413	CcSEcCtD
Daunorubicin—Abdominal pain—Dactinomycin—kidney cancer	1.78e-05	0.000413	CcSEcCtD
Daunorubicin—Visual impairment—Capecitabine—kidney cancer	1.78e-05	0.000412	CcSEcCtD
Daunorubicin—Anaphylactoid reaction—Doxorubicin—kidney cancer	1.78e-05	0.000412	CcSEcCtD
Daunorubicin—Asthenia—Sorafenib—kidney cancer	1.77e-05	0.000411	CcSEcCtD
Daunorubicin—Malaise—Paclitaxel—kidney cancer	1.76e-05	0.000409	CcSEcCtD
Daunorubicin—Cardiac failure—Doxorubicin—kidney cancer	1.76e-05	0.000408	CcSEcCtD
Daunorubicin—Syncope—Paclitaxel—kidney cancer	1.76e-05	0.000407	CcSEcCtD
Daunorubicin—Leukopenia—Paclitaxel—kidney cancer	1.75e-05	0.000406	CcSEcCtD
Daunorubicin—Hypersensitivity—Sunitinib—kidney cancer	1.75e-05	0.000406	CcSEcCtD
Daunorubicin—Decreased appetite—Vincristine—kidney cancer	1.75e-05	0.000405	CcSEcCtD
Daunorubicin—Pruritus—Sorafenib—kidney cancer	1.75e-05	0.000405	CcSEcCtD
Daunorubicin—Vomiting—Erlotinib—kidney cancer	1.75e-05	0.000405	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	1.74e-05	0.000403	CcSEcCtD
Daunorubicin—Fatigue—Vincristine—kidney cancer	1.73e-05	0.000402	CcSEcCtD
Daunorubicin—Rash—Erlotinib—kidney cancer	1.73e-05	0.000402	CcSEcCtD
Daunorubicin—Dermatitis—Erlotinib—kidney cancer	1.73e-05	0.000401	CcSEcCtD
Daunorubicin—Palpitations—Paclitaxel—kidney cancer	1.73e-05	0.000401	CcSEcCtD
Daunorubicin—Insomnia—Gemcitabine—kidney cancer	1.73e-05	0.0004	CcSEcCtD
Daunorubicin—Headache—Erlotinib—kidney cancer	1.72e-05	0.000399	CcSEcCtD
Daunorubicin—Tinnitus—Capecitabine—kidney cancer	1.72e-05	0.000399	CcSEcCtD
Daunorubicin—Loss of consciousness—Paclitaxel—kidney cancer	1.72e-05	0.000399	CcSEcCtD
Daunorubicin—Pain—Vincristine—kidney cancer	1.72e-05	0.000399	CcSEcCtD
Daunorubicin—Constipation—Vincristine—kidney cancer	1.72e-05	0.000399	CcSEcCtD
Daunorubicin—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	1.72e-05	0.000399	CcSEcCtD
Daunorubicin—Cardiac disorder—Capecitabine—kidney cancer	1.71e-05	0.000397	CcSEcCtD
Daunorubicin—Flushing—Capecitabine—kidney cancer	1.71e-05	0.000397	CcSEcCtD
Daunorubicin—Cough—Paclitaxel—kidney cancer	1.71e-05	0.000396	CcSEcCtD
Daunorubicin—Asthenia—Sunitinib—kidney cancer	1.71e-05	0.000396	CcSEcCtD
Daunorubicin—Dyspnoea—Gemcitabine—kidney cancer	1.7e-05	0.000394	CcSEcCtD
Daunorubicin—Nausea—Vinblastine—kidney cancer	1.7e-05	0.000394	CcSEcCtD
Daunorubicin—Somnolence—Gemcitabine—kidney cancer	1.7e-05	0.000393	CcSEcCtD
Daunorubicin—Convulsion—Paclitaxel—kidney cancer	1.7e-05	0.000393	CcSEcCtD
Daunorubicin—Affect lability—Doxorubicin—kidney cancer	1.69e-05	0.000392	CcSEcCtD
Daunorubicin—Nausea—Everolimus—kidney cancer	1.69e-05	0.000392	CcSEcCtD
Daunorubicin—Diarrhoea—Sorafenib—kidney cancer	1.69e-05	0.000392	CcSEcCtD
Daunorubicin—Hypertension—Paclitaxel—kidney cancer	1.69e-05	0.000392	CcSEcCtD
Daunorubicin—Pruritus—Sunitinib—kidney cancer	1.68e-05	0.00039	CcSEcCtD
Daunorubicin—Arthralgia—Paclitaxel—kidney cancer	1.67e-05	0.000386	CcSEcCtD
Daunorubicin—Chest pain—Paclitaxel—kidney cancer	1.67e-05	0.000386	CcSEcCtD
Daunorubicin—Myalgia—Paclitaxel—kidney cancer	1.67e-05	0.000386	CcSEcCtD
Daunorubicin—Anxiety—Paclitaxel—kidney cancer	1.66e-05	0.000385	CcSEcCtD
Daunorubicin—Decreased appetite—Gemcitabine—kidney cancer	1.66e-05	0.000385	CcSEcCtD
Daunorubicin—Hypersensitivity—Dactinomycin—kidney cancer	1.66e-05	0.000385	CcSEcCtD
Daunorubicin—Chills—Capecitabine—kidney cancer	1.66e-05	0.000384	CcSEcCtD
Daunorubicin—Arrhythmia—Capecitabine—kidney cancer	1.65e-05	0.000382	CcSEcCtD
Daunorubicin—Discomfort—Paclitaxel—kidney cancer	1.65e-05	0.000382	CcSEcCtD
Daunorubicin—Fatigue—Gemcitabine—kidney cancer	1.64e-05	0.000381	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Vincristine—kidney cancer	1.64e-05	0.000381	CcSEcCtD
Daunorubicin—Cardiac arrest—Doxorubicin—kidney cancer	1.63e-05	0.000379	CcSEcCtD
Daunorubicin—Dizziness—Sorafenib—kidney cancer	1.63e-05	0.000379	CcSEcCtD
Daunorubicin—Pain—Gemcitabine—kidney cancer	1.63e-05	0.000378	CcSEcCtD
Daunorubicin—Constipation—Gemcitabine—kidney cancer	1.63e-05	0.000378	CcSEcCtD
Daunorubicin—Nausea—Erlotinib—kidney cancer	1.63e-05	0.000378	CcSEcCtD
Daunorubicin—Alopecia—Capecitabine—kidney cancer	1.63e-05	0.000378	CcSEcCtD
Daunorubicin—Dry mouth—Paclitaxel—kidney cancer	1.63e-05	0.000378	CcSEcCtD
Daunorubicin—Mood swings—Doxorubicin—kidney cancer	1.63e-05	0.000378	CcSEcCtD
Daunorubicin—Diarrhoea—Sunitinib—kidney cancer	1.63e-05	0.000377	CcSEcCtD
Daunorubicin—Ataxia—Doxorubicin—kidney cancer	1.62e-05	0.000375	CcSEcCtD
Daunorubicin—Asthenia—Dactinomycin—kidney cancer	1.62e-05	0.000374	CcSEcCtD
Daunorubicin—Confusional state—Paclitaxel—kidney cancer	1.61e-05	0.000373	CcSEcCtD
Daunorubicin—Erythema—Capecitabine—kidney cancer	1.61e-05	0.000372	CcSEcCtD
Daunorubicin—Dehydration—Doxorubicin—kidney cancer	1.6e-05	0.000371	CcSEcCtD
Daunorubicin—Oedema—Paclitaxel—kidney cancer	1.6e-05	0.00037	CcSEcCtD
Daunorubicin—Anaphylactic shock—Paclitaxel—kidney cancer	1.6e-05	0.00037	CcSEcCtD
Daunorubicin—Abdominal pain—Vincristine—kidney cancer	1.59e-05	0.000369	CcSEcCtD
Daunorubicin—Body temperature increased—Vincristine—kidney cancer	1.59e-05	0.000369	CcSEcCtD
Daunorubicin—Infection—Paclitaxel—kidney cancer	1.59e-05	0.000368	CcSEcCtD
Daunorubicin—Dry skin—Doxorubicin—kidney cancer	1.58e-05	0.000365	CcSEcCtD
Daunorubicin—Dysgeusia—Capecitabine—kidney cancer	1.57e-05	0.000365	CcSEcCtD
Daunorubicin—Dizziness—Sunitinib—kidney cancer	1.57e-05	0.000365	CcSEcCtD
Daunorubicin—Feeling abnormal—Gemcitabine—kidney cancer	1.57e-05	0.000365	CcSEcCtD
Daunorubicin—Shock—Paclitaxel—kidney cancer	1.57e-05	0.000364	CcSEcCtD
Daunorubicin—Vomiting—Sorafenib—kidney cancer	1.57e-05	0.000364	CcSEcCtD
Daunorubicin—Thrombocytopenia—Paclitaxel—kidney cancer	1.56e-05	0.000363	CcSEcCtD
Daunorubicin—Tachycardia—Paclitaxel—kidney cancer	1.56e-05	0.000361	CcSEcCtD
Daunorubicin—Rash—Sorafenib—kidney cancer	1.56e-05	0.000361	CcSEcCtD
Daunorubicin—Dermatitis—Sorafenib—kidney cancer	1.56e-05	0.000361	CcSEcCtD
Daunorubicin—Back pain—Capecitabine—kidney cancer	1.55e-05	0.00036	CcSEcCtD
Daunorubicin—Headache—Sorafenib—kidney cancer	1.55e-05	0.000359	CcSEcCtD
Daunorubicin—Hyperhidrosis—Paclitaxel—kidney cancer	1.54e-05	0.000358	CcSEcCtD
Daunorubicin—Diarrhoea—Dactinomycin—kidney cancer	1.54e-05	0.000357	CcSEcCtD
Daunorubicin—Anorexia—Paclitaxel—kidney cancer	1.52e-05	0.000353	CcSEcCtD
Daunorubicin—Gastritis—Doxorubicin—kidney cancer	1.52e-05	0.000353	CcSEcCtD
Daunorubicin—Vomiting—Sunitinib—kidney cancer	1.51e-05	0.000351	CcSEcCtD
Daunorubicin—Body temperature increased—Gemcitabine—kidney cancer	1.51e-05	0.00035	CcSEcCtD
Daunorubicin—Tremor—Capecitabine—kidney cancer	1.5e-05	0.000349	CcSEcCtD
Daunorubicin—Rash—Sunitinib—kidney cancer	1.5e-05	0.000348	CcSEcCtD
Daunorubicin—Dermatitis—Sunitinib—kidney cancer	1.5e-05	0.000347	CcSEcCtD
Daunorubicin—Ill-defined disorder—Capecitabine—kidney cancer	1.49e-05	0.000346	CcSEcCtD
Daunorubicin—Headache—Sunitinib—kidney cancer	1.49e-05	0.000345	CcSEcCtD
Daunorubicin—Dysphagia—Doxorubicin—kidney cancer	1.49e-05	0.000345	CcSEcCtD
Daunorubicin—Anaemia—Capecitabine—kidney cancer	1.48e-05	0.000344	CcSEcCtD
Daunorubicin—Hypersensitivity—Vincristine—kidney cancer	1.48e-05	0.000344	CcSEcCtD
Daunorubicin—Nausea—Sorafenib—kidney cancer	1.47e-05	0.00034	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	1.46e-05	0.000337	CcSEcCtD
Daunorubicin—Malaise—Capecitabine—kidney cancer	1.45e-05	0.000336	CcSEcCtD
Daunorubicin—Angina pectoris—Doxorubicin—kidney cancer	1.45e-05	0.000336	CcSEcCtD
Daunorubicin—Insomnia—Paclitaxel—kidney cancer	1.44e-05	0.000335	CcSEcCtD
Daunorubicin—Asthenia—Vincristine—kidney cancer	1.44e-05	0.000335	CcSEcCtD
Daunorubicin—Syncope—Capecitabine—kidney cancer	1.44e-05	0.000334	CcSEcCtD
Daunorubicin—Leukopenia—Capecitabine—kidney cancer	1.44e-05	0.000333	CcSEcCtD
Daunorubicin—Vomiting—Dactinomycin—kidney cancer	1.43e-05	0.000332	CcSEcCtD
Daunorubicin—Dyspnoea—Paclitaxel—kidney cancer	1.42e-05	0.00033	CcSEcCtD
Daunorubicin—Somnolence—Paclitaxel—kidney cancer	1.42e-05	0.000329	CcSEcCtD
Daunorubicin—Palpitations—Capecitabine—kidney cancer	1.42e-05	0.000329	CcSEcCtD
Daunorubicin—Rash—Dactinomycin—kidney cancer	1.42e-05	0.000329	CcSEcCtD
Daunorubicin—Nausea—Sunitinib—kidney cancer	1.41e-05	0.000327	CcSEcCtD
Daunorubicin—Loss of consciousness—Capecitabine—kidney cancer	1.41e-05	0.000327	CcSEcCtD
Daunorubicin—Pancytopenia—Doxorubicin—kidney cancer	1.41e-05	0.000327	CcSEcCtD
Daunorubicin—Cough—Capecitabine—kidney cancer	1.4e-05	0.000325	CcSEcCtD
Daunorubicin—Neutropenia—Doxorubicin—kidney cancer	1.39e-05	0.000322	CcSEcCtD
Daunorubicin—Dysuria—Doxorubicin—kidney cancer	1.39e-05	0.000322	CcSEcCtD
Daunorubicin—Decreased appetite—Paclitaxel—kidney cancer	1.39e-05	0.000322	CcSEcCtD
Daunorubicin—Hypertension—Capecitabine—kidney cancer	1.39e-05	0.000322	CcSEcCtD
Daunorubicin—Fatigue—Paclitaxel—kidney cancer	1.38e-05	0.000319	CcSEcCtD
Daunorubicin—Diarrhoea—Vincristine—kidney cancer	1.38e-05	0.000319	CcSEcCtD
Daunorubicin—Asthenia—Gemcitabine—kidney cancer	1.37e-05	0.000317	CcSEcCtD
Daunorubicin—Arthralgia—Capecitabine—kidney cancer	1.37e-05	0.000317	CcSEcCtD
Daunorubicin—Chest pain—Capecitabine—kidney cancer	1.37e-05	0.000317	CcSEcCtD
Daunorubicin—Myalgia—Capecitabine—kidney cancer	1.37e-05	0.000317	CcSEcCtD
Daunorubicin—Constipation—Paclitaxel—kidney cancer	1.37e-05	0.000317	CcSEcCtD
Daunorubicin—Pain—Paclitaxel—kidney cancer	1.37e-05	0.000317	CcSEcCtD
Daunorubicin—Anxiety—Capecitabine—kidney cancer	1.36e-05	0.000316	CcSEcCtD
Daunorubicin—Discomfort—Capecitabine—kidney cancer	1.35e-05	0.000313	CcSEcCtD
Daunorubicin—Pruritus—Gemcitabine—kidney cancer	1.35e-05	0.000313	CcSEcCtD
Daunorubicin—Dry mouth—Capecitabine—kidney cancer	1.34e-05	0.00031	CcSEcCtD
Daunorubicin—Nausea—Dactinomycin—kidney cancer	1.34e-05	0.00031	CcSEcCtD
Daunorubicin—Dizziness—Vincristine—kidney cancer	1.33e-05	0.000308	CcSEcCtD
Daunorubicin—Confusional state—Capecitabine—kidney cancer	1.32e-05	0.000306	CcSEcCtD
Daunorubicin—Feeling abnormal—Paclitaxel—kidney cancer	1.32e-05	0.000305	CcSEcCtD
Daunorubicin—Oedema—Capecitabine—kidney cancer	1.31e-05	0.000304	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Paclitaxel—kidney cancer	1.31e-05	0.000303	CcSEcCtD
Daunorubicin—Diarrhoea—Gemcitabine—kidney cancer	1.31e-05	0.000303	CcSEcCtD
Daunorubicin—Renal failure—Doxorubicin—kidney cancer	1.3e-05	0.000302	CcSEcCtD
Daunorubicin—Infection—Capecitabine—kidney cancer	1.3e-05	0.000302	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Doxorubicin—kidney cancer	1.3e-05	0.000301	CcSEcCtD
Daunorubicin—Stomatitis—Doxorubicin—kidney cancer	1.29e-05	0.000299	CcSEcCtD
Daunorubicin—Shock—Capecitabine—kidney cancer	1.29e-05	0.000299	CcSEcCtD
Daunorubicin—Conjunctivitis—Doxorubicin—kidney cancer	1.29e-05	0.000299	CcSEcCtD
Daunorubicin—Thrombocytopenia—Capecitabine—kidney cancer	1.28e-05	0.000298	CcSEcCtD
Daunorubicin—Tachycardia—Capecitabine—kidney cancer	1.28e-05	0.000297	CcSEcCtD
Daunorubicin—Vomiting—Vincristine—kidney cancer	1.28e-05	0.000296	CcSEcCtD
Daunorubicin—Urticaria—Paclitaxel—kidney cancer	1.27e-05	0.000294	CcSEcCtD
Daunorubicin—Rash—Vincristine—kidney cancer	1.27e-05	0.000294	CcSEcCtD
Daunorubicin—Hyperhidrosis—Capecitabine—kidney cancer	1.27e-05	0.000294	CcSEcCtD
Daunorubicin—Dermatitis—Vincristine—kidney cancer	1.27e-05	0.000294	CcSEcCtD
Daunorubicin—Abdominal pain—Paclitaxel—kidney cancer	1.26e-05	0.000293	CcSEcCtD
Daunorubicin—Body temperature increased—Paclitaxel—kidney cancer	1.26e-05	0.000293	CcSEcCtD
Daunorubicin—Headache—Vincristine—kidney cancer	1.26e-05	0.000292	CcSEcCtD
Daunorubicin—Anorexia—Capecitabine—kidney cancer	1.25e-05	0.00029	CcSEcCtD
Daunorubicin—Sinusitis—Doxorubicin—kidney cancer	1.24e-05	0.000288	CcSEcCtD
Daunorubicin—Vomiting—Gemcitabine—kidney cancer	1.21e-05	0.000281	CcSEcCtD
Daunorubicin—Rash—Gemcitabine—kidney cancer	1.2e-05	0.000279	CcSEcCtD
Daunorubicin—Dermatitis—Gemcitabine—kidney cancer	1.2e-05	0.000279	CcSEcCtD
Daunorubicin—Headache—Gemcitabine—kidney cancer	1.2e-05	0.000277	CcSEcCtD
Daunorubicin—Nausea—Vincristine—kidney cancer	1.19e-05	0.000277	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Capecitabine—kidney cancer	1.19e-05	0.000277	CcSEcCtD
Daunorubicin—Rhinitis—Doxorubicin—kidney cancer	1.19e-05	0.000276	CcSEcCtD
Daunorubicin—Insomnia—Capecitabine—kidney cancer	1.19e-05	0.000275	CcSEcCtD
Daunorubicin—Hypersensitivity—Paclitaxel—kidney cancer	1.18e-05	0.000273	CcSEcCtD
Daunorubicin—Dyspnoea—Capecitabine—kidney cancer	1.17e-05	0.000271	CcSEcCtD
Daunorubicin—Visual impairment—Doxorubicin—kidney cancer	1.15e-05	0.000266	CcSEcCtD
Daunorubicin—Asthenia—Paclitaxel—kidney cancer	1.15e-05	0.000266	CcSEcCtD
Daunorubicin—Decreased appetite—Capecitabine—kidney cancer	1.14e-05	0.000264	CcSEcCtD
Daunorubicin—Nausea—Gemcitabine—kidney cancer	1.13e-05	0.000263	CcSEcCtD
Daunorubicin—Fatigue—Capecitabine—kidney cancer	1.13e-05	0.000262	CcSEcCtD
Daunorubicin—Pruritus—Paclitaxel—kidney cancer	1.13e-05	0.000262	CcSEcCtD
Daunorubicin—Pain—Capecitabine—kidney cancer	1.12e-05	0.00026	CcSEcCtD
Daunorubicin—Constipation—Capecitabine—kidney cancer	1.12e-05	0.00026	CcSEcCtD
Daunorubicin—Tinnitus—Doxorubicin—kidney cancer	1.11e-05	0.000257	CcSEcCtD
Daunorubicin—Cardiac disorder—Doxorubicin—kidney cancer	1.1e-05	0.000256	CcSEcCtD
Daunorubicin—Flushing—Doxorubicin—kidney cancer	1.1e-05	0.000256	CcSEcCtD
Daunorubicin—Diarrhoea—Paclitaxel—kidney cancer	1.09e-05	0.000253	CcSEcCtD
Daunorubicin—Feeling abnormal—Capecitabine—kidney cancer	1.08e-05	0.00025	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Capecitabine—kidney cancer	1.07e-05	0.000249	CcSEcCtD
Daunorubicin—Chills—Doxorubicin—kidney cancer	1.07e-05	0.000247	CcSEcCtD
Daunorubicin—Arrhythmia—Doxorubicin—kidney cancer	1.06e-05	0.000246	CcSEcCtD
Daunorubicin—Dizziness—Paclitaxel—kidney cancer	1.06e-05	0.000245	CcSEcCtD
Daunorubicin—Alopecia—Doxorubicin—kidney cancer	1.05e-05	0.000244	CcSEcCtD
Daunorubicin—Urticaria—Capecitabine—kidney cancer	1.04e-05	0.000241	CcSEcCtD
Daunorubicin—Abdominal pain—Capecitabine—kidney cancer	1.04e-05	0.00024	CcSEcCtD
Daunorubicin—Body temperature increased—Capecitabine—kidney cancer	1.04e-05	0.00024	CcSEcCtD
Daunorubicin—Erythema—Doxorubicin—kidney cancer	1.04e-05	0.00024	CcSEcCtD
Daunorubicin—Vomiting—Paclitaxel—kidney cancer	1.02e-05	0.000235	CcSEcCtD
Daunorubicin—Dysgeusia—Doxorubicin—kidney cancer	1.01e-05	0.000235	CcSEcCtD
Daunorubicin—Rash—Paclitaxel—kidney cancer	1.01e-05	0.000234	CcSEcCtD
Daunorubicin—Dermatitis—Paclitaxel—kidney cancer	1.01e-05	0.000233	CcSEcCtD
Daunorubicin—Back pain—Doxorubicin—kidney cancer	1e-05	0.000232	CcSEcCtD
Daunorubicin—Headache—Paclitaxel—kidney cancer	1e-05	0.000232	CcSEcCtD
Daunorubicin—Hypersensitivity—Capecitabine—kidney cancer	9.66e-06	0.000224	CcSEcCtD
Daunorubicin—Ill-defined disorder—Doxorubicin—kidney cancer	9.61e-06	0.000223	CcSEcCtD
Daunorubicin—Anaemia—Doxorubicin—kidney cancer	9.57e-06	0.000222	CcSEcCtD
Daunorubicin—Agitation—Doxorubicin—kidney cancer	9.51e-06	0.000221	CcSEcCtD
Daunorubicin—Nausea—Paclitaxel—kidney cancer	9.49e-06	0.00022	CcSEcCtD
Daunorubicin—Asthenia—Capecitabine—kidney cancer	9.41e-06	0.000218	CcSEcCtD
Daunorubicin—Malaise—Doxorubicin—kidney cancer	9.34e-06	0.000216	CcSEcCtD
Daunorubicin—Syncope—Doxorubicin—kidney cancer	9.28e-06	0.000215	CcSEcCtD
Daunorubicin—Pruritus—Capecitabine—kidney cancer	9.27e-06	0.000215	CcSEcCtD
Daunorubicin—Leukopenia—Doxorubicin—kidney cancer	9.27e-06	0.000215	CcSEcCtD
Daunorubicin—Palpitations—Doxorubicin—kidney cancer	9.15e-06	0.000212	CcSEcCtD
Daunorubicin—Loss of consciousness—Doxorubicin—kidney cancer	9.1e-06	0.000211	CcSEcCtD
Daunorubicin—Cough—Doxorubicin—kidney cancer	9.03e-06	0.000209	CcSEcCtD
Daunorubicin—Convulsion—Doxorubicin—kidney cancer	8.97e-06	0.000208	CcSEcCtD
Daunorubicin—Diarrhoea—Capecitabine—kidney cancer	8.97e-06	0.000208	CcSEcCtD
Daunorubicin—Hypertension—Doxorubicin—kidney cancer	8.94e-06	0.000207	CcSEcCtD
Daunorubicin—Arthralgia—Doxorubicin—kidney cancer	8.81e-06	0.000204	CcSEcCtD
Daunorubicin—Chest pain—Doxorubicin—kidney cancer	8.81e-06	0.000204	CcSEcCtD
Daunorubicin—Myalgia—Doxorubicin—kidney cancer	8.81e-06	0.000204	CcSEcCtD
Daunorubicin—Anxiety—Doxorubicin—kidney cancer	8.78e-06	0.000204	CcSEcCtD
Daunorubicin—Discomfort—Doxorubicin—kidney cancer	8.71e-06	0.000202	CcSEcCtD
Daunorubicin—Dizziness—Capecitabine—kidney cancer	8.67e-06	0.000201	CcSEcCtD
Daunorubicin—Dry mouth—Doxorubicin—kidney cancer	8.62e-06	0.0002	CcSEcCtD
Daunorubicin—Confusional state—Doxorubicin—kidney cancer	8.52e-06	0.000198	CcSEcCtD
Daunorubicin—Oedema—Doxorubicin—kidney cancer	8.45e-06	0.000196	CcSEcCtD
Daunorubicin—Anaphylactic shock—Doxorubicin—kidney cancer	8.45e-06	0.000196	CcSEcCtD
Daunorubicin—Infection—Doxorubicin—kidney cancer	8.39e-06	0.000195	CcSEcCtD
Daunorubicin—Vomiting—Capecitabine—kidney cancer	8.33e-06	0.000193	CcSEcCtD
Daunorubicin—Shock—Doxorubicin—kidney cancer	8.31e-06	0.000193	CcSEcCtD
Daunorubicin—Thrombocytopenia—Doxorubicin—kidney cancer	8.27e-06	0.000192	CcSEcCtD
Daunorubicin—Rash—Capecitabine—kidney cancer	8.27e-06	0.000192	CcSEcCtD
Daunorubicin—Dermatitis—Capecitabine—kidney cancer	8.26e-06	0.000191	CcSEcCtD
Daunorubicin—Tachycardia—Doxorubicin—kidney cancer	8.25e-06	0.000191	CcSEcCtD
Daunorubicin—Headache—Capecitabine—kidney cancer	8.21e-06	0.00019	CcSEcCtD
Daunorubicin—Hyperhidrosis—Doxorubicin—kidney cancer	8.17e-06	0.000189	CcSEcCtD
Daunorubicin—Anorexia—Doxorubicin—kidney cancer	8.05e-06	0.000187	CcSEcCtD
Daunorubicin—Nausea—Capecitabine—kidney cancer	7.79e-06	0.000181	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	7.7e-06	0.000179	CcSEcCtD
Daunorubicin—Insomnia—Doxorubicin—kidney cancer	7.64e-06	0.000177	CcSEcCtD
Daunorubicin—Dyspnoea—Doxorubicin—kidney cancer	7.53e-06	0.000175	CcSEcCtD
Daunorubicin—Somnolence—Doxorubicin—kidney cancer	7.51e-06	0.000174	CcSEcCtD
Daunorubicin—Decreased appetite—Doxorubicin—kidney cancer	7.35e-06	0.00017	CcSEcCtD
Daunorubicin—Fatigue—Doxorubicin—kidney cancer	7.29e-06	0.000169	CcSEcCtD
Daunorubicin—Constipation—Doxorubicin—kidney cancer	7.23e-06	0.000168	CcSEcCtD
Daunorubicin—Pain—Doxorubicin—kidney cancer	7.23e-06	0.000168	CcSEcCtD
Daunorubicin—Feeling abnormal—Doxorubicin—kidney cancer	6.96e-06	0.000161	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Doxorubicin—kidney cancer	6.91e-06	0.00016	CcSEcCtD
Daunorubicin—Urticaria—Doxorubicin—kidney cancer	6.71e-06	0.000156	CcSEcCtD
Daunorubicin—Abdominal pain—Doxorubicin—kidney cancer	6.68e-06	0.000155	CcSEcCtD
Daunorubicin—Body temperature increased—Doxorubicin—kidney cancer	6.68e-06	0.000155	CcSEcCtD
Daunorubicin—Hypersensitivity—Doxorubicin—kidney cancer	6.23e-06	0.000144	CcSEcCtD
Daunorubicin—Asthenia—Doxorubicin—kidney cancer	6.06e-06	0.000141	CcSEcCtD
Daunorubicin—Pruritus—Doxorubicin—kidney cancer	5.98e-06	0.000139	CcSEcCtD
Daunorubicin—Diarrhoea—Doxorubicin—kidney cancer	5.78e-06	0.000134	CcSEcCtD
Daunorubicin—Dizziness—Doxorubicin—kidney cancer	5.59e-06	0.00013	CcSEcCtD
Daunorubicin—Vomiting—Doxorubicin—kidney cancer	5.37e-06	0.000125	CcSEcCtD
Daunorubicin—Rash—Doxorubicin—kidney cancer	5.33e-06	0.000124	CcSEcCtD
Daunorubicin—Dermatitis—Doxorubicin—kidney cancer	5.32e-06	0.000123	CcSEcCtD
Daunorubicin—Headache—Doxorubicin—kidney cancer	5.29e-06	0.000123	CcSEcCtD
Daunorubicin—Nausea—Doxorubicin—kidney cancer	5.02e-06	0.000116	CcSEcCtD
Daunorubicin—CYP3A5—Metabolism—CA9—kidney cancer	2.33e-06	0.000123	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.33e-06	0.000123	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—ABCB1—kidney cancer	2.33e-06	0.000123	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—BCHE—kidney cancer	2.32e-06	0.000123	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CA2—kidney cancer	2.32e-06	0.000123	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GSTT1—kidney cancer	2.32e-06	0.000123	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ACHE—kidney cancer	2.32e-06	0.000123	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.32e-06	0.000123	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—SLC5A5—kidney cancer	2.29e-06	0.000121	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—MAPK1—kidney cancer	2.28e-06	0.000121	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.27e-06	0.00012	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ALAD—kidney cancer	2.26e-06	0.00012	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—GSTM1—kidney cancer	2.26e-06	0.00012	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.25e-06	0.000119	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—BCHE—kidney cancer	2.24e-06	0.000119	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—SCARB1—kidney cancer	2.22e-06	0.000117	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—SLC5A5—kidney cancer	2.22e-06	0.000117	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—SLC2A1—kidney cancer	2.21e-06	0.000117	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.21e-06	0.000117	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ST3GAL2—kidney cancer	2.21e-06	0.000117	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.21e-06	0.000117	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CA9—kidney cancer	2.2e-06	0.000116	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTGS1—kidney cancer	2.2e-06	0.000116	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—SCARB1—kidney cancer	2.2e-06	0.000116	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2.19e-06	0.000116	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PPAT—kidney cancer	2.18e-06	0.000115	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GLIPR1—kidney cancer	2.18e-06	0.000115	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTGS1—kidney cancer	2.17e-06	0.000115	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—POMC—kidney cancer	2.17e-06	0.000115	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ALDH1A1—kidney cancer	2.16e-06	0.000114	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PSMD7—kidney cancer	2.15e-06	0.000114	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.15e-06	0.000114	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.15e-06	0.000114	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—SLC2A1—kidney cancer	2.14e-06	0.000113	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—CYP1A1—kidney cancer	2.14e-06	0.000113	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.14e-06	0.000113	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CDKN2B—kidney cancer	2.14e-06	0.000113	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.13e-06	0.000113	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PSMD7—kidney cancer	2.13e-06	0.000113	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.13e-06	0.000113	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.11e-06	0.000112	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.08e-06	0.00011	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PGK1—kidney cancer	2.07e-06	0.000109	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SLC5A3—kidney cancer	2.07e-06	0.000109	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PDHB—kidney cancer	2.06e-06	0.000109	CbGpPWpGaD
Daunorubicin—CYP3A4—Biological oxidations—POMC—kidney cancer	2.06e-06	0.000109	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—BCHE—kidney cancer	2.04e-06	0.000108	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—LDHB—kidney cancer	2.03e-06	0.000107	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—APRT—kidney cancer	2.03e-06	0.000107	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—FH—kidney cancer	2.03e-06	0.000107	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—BCHE—kidney cancer	2.02e-06	0.000107	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—SLC5A5—kidney cancer	2.02e-06	0.000107	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—SLC5A5—kidney cancer	2e-06	0.000106	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CRABP1—kidney cancer	1.98e-06	0.000105	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.98e-06	0.000105	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—SLC2A1—kidney cancer	1.95e-06	0.000103	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CCBL1—kidney cancer	1.94e-06	0.000103	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—SLC2A1—kidney cancer	1.93e-06	0.000102	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.93e-06	0.000102	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—TP53—kidney cancer	1.92e-06	0.000101	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GPC3—kidney cancer	1.9e-06	0.000101	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.87e-06	9.91e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CRABP1—kidney cancer	1.87e-06	9.9e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.86e-06	9.83e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CA2—kidney cancer	1.85e-06	9.8e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GSTP1—kidney cancer	1.85e-06	9.77e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ITPR2—kidney cancer	1.84e-06	9.75e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.84e-06	9.73e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.82e-06	9.65e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.81e-06	9.59e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ALAD—kidney cancer	1.81e-06	9.55e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GSTP1—kidney cancer	1.79e-06	9.45e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.77e-06	9.39e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.76e-06	9.32e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.76e-06	9.31e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CA9—kidney cancer	1.76e-06	9.3e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—ABCB1—kidney cancer	1.75e-06	9.25e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ITPR2—kidney cancer	1.74e-06	9.21e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.74e-06	9.18e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PTGS2—kidney cancer	1.73e-06	9.14e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.72e-06	9.11e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HIF1A—kidney cancer	1.71e-06	9.04e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TSC2—kidney cancer	1.7e-06	9.01e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GSTM1—kidney cancer	1.7e-06	8.98e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—ABCB1—kidney cancer	1.69e-06	8.95e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.68e-06	8.9e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PPAT—kidney cancer	1.68e-06	8.9e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GSTT1—kidney cancer	1.68e-06	8.89e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ACHE—kidney cancer	1.68e-06	8.89e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.65e-06	8.74e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PGK1—kidney cancer	1.65e-06	8.74e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GSTM1—kidney cancer	1.64e-06	8.68e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.64e-06	8.67e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GSTP1—kidney cancer	1.63e-06	8.6e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—LDHB—kidney cancer	1.62e-06	8.57e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CYP1A1—kidney cancer	1.61e-06	8.51e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GSTP1—kidney cancer	1.61e-06	8.51e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.6e-06	8.49e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—POMC—kidney cancer	1.6e-06	8.45e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—SCARB1—kidney cancer	1.59e-06	8.41e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GSTT1—kidney cancer	1.59e-06	8.4e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ACHE—kidney cancer	1.59e-06	8.4e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTGS1—kidney cancer	1.57e-06	8.33e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—FH—kidney cancer	1.56e-06	8.27e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—APRT—kidney cancer	1.56e-06	8.27e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CYP1A1—kidney cancer	1.56e-06	8.23e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PSMD7—kidney cancer	1.54e-06	8.17e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ABCB1—kidney cancer	1.54e-06	8.14e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ABCB1—kidney cancer	1.52e-06	8.05e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PTEN—kidney cancer	1.51e-06	7.97e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.51e-06	7.97e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—APC—kidney cancer	1.5e-06	7.96e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—KIT—kidney cancer	1.5e-06	7.96e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—SCARB1—kidney cancer	1.5e-06	7.95e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CRABP1—kidney cancer	1.5e-06	7.91e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GSTM1—kidney cancer	1.49e-06	7.9e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTGS1—kidney cancer	1.49e-06	7.87e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GSTM1—kidney cancer	1.48e-06	7.82e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GPC3—kidney cancer	1.47e-06	7.78e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—BCHE—kidney cancer	1.46e-06	7.74e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PSMD7—kidney cancer	1.46e-06	7.72e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.46e-06	7.71e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—SLC5A5—kidney cancer	1.45e-06	7.65e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CA2—kidney cancer	1.43e-06	7.56e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CYP1A1—kidney cancer	1.42e-06	7.49e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—BRAF—kidney cancer	1.41e-06	7.48e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CA9—kidney cancer	1.4e-06	7.43e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CYP1A1—kidney cancer	1.4e-06	7.41e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—SLC2A1—kidney cancer	1.4e-06	7.39e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ALAD—kidney cancer	1.39e-06	7.37e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ITPR2—kidney cancer	1.39e-06	7.35e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—BCHE—kidney cancer	1.38e-06	7.31e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.37e-06	7.26e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—SLC5A5—kidney cancer	1.37e-06	7.23e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.36e-06	7.19e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.33e-06	7.03e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.32e-06	6.99e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—SLC2A1—kidney cancer	1.32e-06	6.98e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.28e-06	6.77e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.28e-06	6.76e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.27e-06	6.74e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PGK1—kidney cancer	1.27e-06	6.74e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PTGS2—kidney cancer	1.27e-06	6.74e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTT1—kidney cancer	1.27e-06	6.71e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ACHE—kidney cancer	1.27e-06	6.71e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—LDHB—kidney cancer	1.25e-06	6.61e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SCARB1—kidney cancer	1.2e-06	6.35e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—POMC—kidney cancer	1.2e-06	6.35e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CRABP1—kidney cancer	1.19e-06	6.32e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTGS1—kidney cancer	1.19e-06	6.28e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—RAF1—kidney cancer	1.18e-06	6.25e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—ERBB2—kidney cancer	1.17e-06	6.18e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PSMD7—kidney cancer	1.16e-06	6.16e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GSTP1—kidney cancer	1.16e-06	6.16e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—POMC—kidney cancer	1.16e-06	6.14e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MTOR—kidney cancer	1.15e-06	6.1e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CD4—kidney cancer	1.15e-06	6.09e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTGS2—kidney cancer	1.14e-06	6.04e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.12e-06	5.9e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PTEN—kidney cancer	1.11e-06	5.88e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ITPR2—kidney cancer	1.11e-06	5.87e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—BCHE—kidney cancer	1.1e-06	5.84e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ABCB1—kidney cancer	1.1e-06	5.83e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GSTP1—kidney cancer	1.1e-06	5.82e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SLC5A5—kidney cancer	1.09e-06	5.77e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CA9—kidney cancer	1.08e-06	5.73e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CDKN1B—kidney cancer	1.08e-06	5.73e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GSTM1—kidney cancer	1.07e-06	5.66e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PIK3CA—kidney cancer	1.06e-06	5.62e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—POMC—kidney cancer	1.06e-06	5.58e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SLC2A1—kidney cancer	1.05e-06	5.57e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—POMC—kidney cancer	1.04e-06	5.53e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ABCB1—kidney cancer	1.04e-06	5.51e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.02e-06	5.41e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CTNNB1—kidney cancer	1.02e-06	5.41e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP1A1—kidney cancer	1.01e-06	5.37e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ACHE—kidney cancer	1.01e-06	5.35e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTT1—kidney cancer	1.01e-06	5.35e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GSTM1—kidney cancer	1.01e-06	5.35e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	1e-06	5.32e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTEN—kidney cancer	9.96e-07	5.27e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SCARB1—kidney cancer	9.58e-07	5.07e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTGS2—kidney cancer	9.57e-07	5.06e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTGS1—kidney cancer	9.48e-07	5.02e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PSMD7—kidney cancer	9.3e-07	4.92e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTGS2—kidney cancer	9.25e-07	4.9e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CRABP1—kidney cancer	9.21e-07	4.87e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—BCHE—kidney cancer	8.82e-07	4.66e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTP1—kidney cancer	8.79e-07	4.65e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SLC5A5—kidney cancer	8.71e-07	4.61e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ITPR2—kidney cancer	8.56e-07	4.53e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MAPK3—kidney cancer	8.51e-07	4.5e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTGS2—kidney cancer	8.42e-07	4.45e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SLC2A1—kidney cancer	8.41e-07	4.45e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTEN—kidney cancer	8.34e-07	4.41e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTGS2—kidney cancer	8.33e-07	4.41e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MYC—kidney cancer	8.28e-07	4.38e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.16e-07	4.32e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MAPK1—kidney cancer	8.1e-07	4.29e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTM1—kidney cancer	8.07e-07	4.27e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTEN—kidney cancer	8.07e-07	4.27e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.87e-07	4.17e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CA—kidney cancer	7.84e-07	4.15e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTT1—kidney cancer	7.81e-07	4.13e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ACHE—kidney cancer	7.81e-07	4.13e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP1A1—kidney cancer	7.65e-07	4.05e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—KRAS—kidney cancer	7.65e-07	4.05e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—POMC—kidney cancer	7.56e-07	4e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SCARB1—kidney cancer	7.39e-07	3.91e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTEN—kidney cancer	7.34e-07	3.88e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTGS1—kidney cancer	7.32e-07	3.87e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTEN—kidney cancer	7.27e-07	3.84e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PSMD7—kidney cancer	7.18e-07	3.8e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—POMC—kidney cancer	7.14e-07	3.78e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.12e-07	3.76e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PIK3CA—kidney cancer	7.03e-07	3.72e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTP1—kidney cancer	7.01e-07	3.71e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—BCHE—kidney cancer	6.8e-07	3.6e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC5A5—kidney cancer	6.72e-07	3.56e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ABCB1—kidney cancer	6.64e-07	3.51e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC2A1—kidney cancer	6.49e-07	3.43e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTM1—kidney cancer	6.45e-07	3.41e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP1A1—kidney cancer	6.11e-07	3.23e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTGS2—kidney cancer	6.03e-07	3.19e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CA—kidney cancer	5.89e-07	3.11e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—POMC—kidney cancer	5.71e-07	3.02e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTGS2—kidney cancer	5.7e-07	3.02e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CA—kidney cancer	5.69e-07	3.01e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTP1—kidney cancer	5.41e-07	2.86e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTEN—kidney cancer	5.26e-07	2.78e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CA—kidney cancer	5.18e-07	2.74e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CA—kidney cancer	5.13e-07	2.71e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ABCB1—kidney cancer	5.12e-07	2.71e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.02e-07	2.66e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTM1—kidney cancer	4.97e-07	2.63e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTEN—kidney cancer	4.97e-07	2.63e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP1A1—kidney cancer	4.72e-07	2.5e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—POMC—kidney cancer	4.56e-07	2.41e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTGS2—kidney cancer	4.55e-07	2.41e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTEN—kidney cancer	3.97e-07	2.1e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CA—kidney cancer	3.71e-07	1.96e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTGS2—kidney cancer	3.63e-07	1.92e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—POMC—kidney cancer	3.52e-07	1.86e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CA—kidney cancer	3.51e-07	1.86e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTEN—kidney cancer	3.17e-07	1.68e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTGS2—kidney cancer	2.8e-07	1.48e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CA—kidney cancer	2.8e-07	1.48e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTEN—kidney cancer	2.45e-07	1.29e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CA—kidney cancer	2.24e-07	1.18e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.73e-07	9.13e-06	CbGpPWpGaD
